Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - WI


VANCOUVER, BC, April 22, 2024 /CNW/ - Trading resumes in:

Company: The Western Investment Company of Canada

TSX-Venture Symbol: WI

All Issues: Yes

Resumption (ET): 9:30 AM  04/23/2024

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 03:24
Verne, a leading sustainable data center operator and developer joins VAXA's Impact Nutrition Program with a mutual commitment to sustainability and an appetite for ACTION. VAXA and our partners can leverage our collective resources to drive...

at 03:15
oToBrite, a leading provider of vision-AI ADAS solutions, has successfully developed a compact all-weather vision-AI Driver Monitoring System (DMS). With a high-sensitivity automotive-grade global shutter image sensor, the system achieves outstanding...

at 03:07
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, welcomes London-based marine engineering & investigations expert Chris Gascoigne, CEng, CMarEng, expanding expertise in Forensic Engineering. Chris Gascoigne oversees...

at 03:00
Clarivate Plc , a leading global provider of transformative intelligence, announced today that OMRON has selected IPfoliotm, an intellectual property management software from Clarivate to transform their IP operations. This solution will enable...

at 03:00
ASE Technology Holding Co., Ltd. , announces its unaudited consolidated net revenues for April 2024. CONSOLIDATED NET REVENUES (UNAUDITED) Apr Mar Apr Sequential YoY (NT$ Million) 2024 2024 2023 Change Change Net Revenues 45,820 45,661 43,315 +0.3 %...

at 03:00
Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of...



News published on and distributed by: